Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		12 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Jun. 30, 2025
Cash Flows From Operating Activities:
Net loss	$ (10,299,566)	$ (11,694,569)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	1,305,090	1,264,138
Accretion of financing costs	307,428	1,172,349
Amortization of right-of-use asset	30,637	25,261
Write-down of inventory to net realizable value	322,058
Stock-based compensation	2,280,860	3,171,116
Change in fair value of derivative liability		(705,184)
Change in fair value of conversion option		250,304
Change in fair value of liability-classified equity-linked contracts		(9,016)
Loss on debt extinguishment		675,648
Loss on private placement		567,161
Changes in operating assets and liabilities:
Accounts receivable	1,598,602	54,000
Inventory	(18,041)	(101,577)
Grant receivables	(217,866)	64,666
Prepaid expenses and other	(2,142,728)	1,167,375
Accounts payable and accrued liabilities	(277,933)	(1,454,022)
Operating lease liability	(27,297)
Net Cash Used in Operating Activities	(7,138,756)	(5,552,350)	$ (28,900,000)
Cash Flows From Investing Activities:
Acquisition of property and equipment	(708,307)	(863,158)
Net Cash Used in Investing Activities	(708,307)	(863,158)
Cash Flows From Financing Activities:
Proceeds from issuance of common shares through At-The-Market offering	22,228,687	6,882,758
Payment of issuance costs of common shares through At-The-Market Offering	(333,430)
Proceeds from subscription agreements		1,900,000
Proceeds from exercise of share purchase warrants	4,400,000
Principal paid on notes payable		(3,600,000)
Net Cash Provided by Financing Activities	26,295,257	5,182,758
Increase (decrease) in Cash and Restricted Cash	18,448,194	(1,232,750)
Cash and Restricted Cash - Beginning of Period	12,474,304	7,001,786	7,001,786
Cash and Restricted Cash - End of Period	$ 30,922,498	$ 5,769,036	$ 12,474,304